Winter 2010: RiverVest co-leads $38.5 million Series B financing to advance breakthrough treatment for ear disorders
Otonomy, Inc. is on the verge of revolutionizing the way doctors treat hearing and balance disorders. “The ear is one of the last great frontiers of pharmaceutical science,” says Jay Lichter, Ph.D., co-founder of Otonomy.
